baber/WOPTO huggingface dataset:
Patent EP-2859475-A2 (EP)
Inventor: BRUESTLE JEREMY J
IPC: G06F7/32
Filed: 2013-06-06
Abstract: The current document is directed to a method and system for data processing in cloud-computing environments and other distributed-computing environments. Implementations of a merge sort suitable for the sorting of data within cloud-computing environments and other distributed-computing environments are disclosed. These implementations takes advantage of the massive parallelism available in cloud-computing environments as well as take into consideration numerous constraints regarding data-storage and data-retrieval operations in a cloud-computing environment. The implementations provide a type of data-sorting method and system that iteratively carries out highly parallel merge-sort operations that can be effectively applied over a range of data-set sizes up to extremely large data sets.
Patent EP-2872159-A2 (EP)
Inventor: MORGAN ADAM
IPC: A61P35/00
Filed: 2013-07-12
Abstract: The present invention in one embodiment provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula (I) are as defined in the specification. The compound of Formula (I) is useful for the treatment of diseases such as a disease selected from the group consisting of multiple myeloma, solid tumors, lymphoma, and leukemia.
Patent EP-2965464-A2 (EP)
Inventor: IOANNIDIS EFSTRATIOS
IPC: H04L9/00
Filed: 2013-12-19
Abstract: A method for counting securely comprising receiving as input a set of records, wherein said set of records comprises at least one record, each record including a set of tokens, wherein said set of tokens comprises at least one token; receiving a separate set of tokens including at least one token and processing the set of records and the separate set of tokens to count in how many records each token belonging to the separate set of tokens appears without learning the contents of any individual record and of any information extracted from the records other than the counts.
Patent EP-2909314-A2 (EP)
Inventor: HERZBERG URI
IPC: C12N5/073
Filed: 2013-10-18
Abstract: Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent amnion-derived cells (AMDACs).
Patent EP-2926065-A2 (EP)
Inventor: ATWOOD RALPH TED
IPC: G06Q30/06
Filed: 2013-11-27
Abstract: A refrigerant life cycle management and compliance tracking and monitoring system and method for maintaining large quantities of refrigerant stored and transported in bulk tanks and containers. The system is customizable and can be used to store, track and compile regulatory and status information about a refrigerant being transported in tanks and any other data relevant to the quality, status or custody of a tank and its contents. The system and method allow access to database information by compliance officers and inspectors for required regulatory reporting. The system and method are accessible through a web browser or mobile application.
Patent EP-2769698-A2 (EP)
Inventor: ÖZYURT CIM
IPC: A61C19/00
Filed: 2014-02-21
Abstract: The dental instrument has a housing unit (10) and a work surface unit (12), which is provided as a support surface (12.1) for a dental workpiece. A machining unit is provided for machining the dental workpiece. The housing unit forms an inclined dust removal surface in an area of the machining unit. The inclined dust removal surface is formed partially to a bottom of cavity formed by the housing unit. An independent claim is included for a method for machining a dental workpiece.
Patent EP-2772442-A2 (EP)
Inventor: ASTON RICHARD W
IPC: B64G1/10
Filed: 2014-02-24
Abstract: A spacecraft (146) may include a module structure (302) having a plurality of module sides (304). The spacecraft (146) may include a central cylinder (150) extending through a center of the spacecraft (146). The central cylinder (150) may be the only closed cross-section extending along a longitudinal axis of the spacecraft (146).
Patent EP-2803357-A2 (EP)
Inventor: LIU JUN
IPC: A61K31/58
Filed: 2005-06-27
Abstract: Described herein are methods of inhibiting angiogenesis, and treating or preventing a disease or disorder (or symptoms thereof) associated with angiogenesis, wherein an anti-angiogenesis compound is administered to a subject.
Patent EP-2818707-A2 (EP)
Inventor: SAEKI SHINJI
IPC: F04B27/18
Filed: 2014-06-26
Abstract: A control valve (1) is configured such that a suction pressure (Ps), which is used to displace a sub-valve element (36) in a valve opening direction after a main valve has been closed, is varied according to a value of current supplied to a solenoid (3). A port (14), which communicates with a crankcase of a compressor, and a port (12), which communicates with a suction chamber of the compressor, are provided in a body (5). A sub-valve chamber (26) whose diameter is larger than that of the main valve hole (20) is formed between the (14) and a main valve hole (20), and a sub-valve is placed in the sub-valve chamber (26).
Patent EP-2824454-A2 (EP)
Inventor: NAKAYAMA YUTA
IPC: H01L27/20
Filed: 2014-07-10
Abstract: A phasing adder and an ultrasound probe therewith are disclosed. The phasing adder (220) includes a delay charge transferring unit (221), preferably a CCD, and a delay adding unit (222). The delay charge transferring unit obtains signal charge in an amount obtained without amplifying according to charge generated in each of a plurality of piezoelectric elements (210). Each of the plurality of piezoelectric elements includes a piezoelectric body (211) to generate charge according to sound pressure of input ultrasound. The delay charge transferring unit holds the signal charge for a predetermined amount of time. The delay adding unit executes phasing adding of an amount of the signal charge held for the predetermined amount of time in the delay charge transferring unit.
Patent EP-2884628-A2 (EP)
Inventor: ALLEN DAVID THOMAS
IPC: H02K1/18
Filed: 2014-11-24
Abstract: A spring bar (112) that connects a stator core to a stator frame. The spring bar assembly (110) includes an attachment member (116) with a hole and a spring bar (112) that tapers from a central region and that includes a hole at each end that aligns with the hole in the attachment member (116). A bolt passes through the hole in the attachment member (116) and the hole in the spring bar (112), where the bolt is used to couple the attachment member (116) to the spring bar (112).
Patent EP-2965179-A2 (EP)
Inventor: ERUCHIMOVITCH BARUCH
IPC: B43K24/10
Filed: 2014-02-26
Abstract: A hybrid input device is described. The hybrid input device includes a stylus for writing on a touchscreen, a writing instrument and a pressure sensor. The hybrid input device also includes an ultrasonic transmitter that transmits an ultrasonic data pattern. The hybrid input device also includes a control element that toggles ultrasonic functionality of the hybrid input device.
Patent EP-3036007-A2 (EP)
Inventor: POLYMEROPOULOS MIHAEL H
IPC: A61K31/165
Filed: 2014-08-22
Abstract: The invention relates generally to the treatment of cancer. One embodiment of the invention provides a method of treating cancer in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
Patent EP-3017816-A2 (EP)
Inventor: KISELEV VSEVOLOD IVANOVICH
IPC: A61K31/404
Filed: 2014-05-19
Abstract: The invention relates to the field of medicine, more specifically pharmacology, and can be used to treat influenza and viral respiratory infections. The aim of the present invention is to broaden the range of agents available for treating acute respiratory diseases and influenza infection by developing an oral medicinal agent based on 3,3-diindolylmethane (DIM) for the treatment of such diseases. A medicinal agent for the treatment of influenza and viral respiratory infections contains 3,3-diindolylmethane, a type A fish oil and an adjuvant in the following ratio: 9-20% by weight 3,3-diindolylmethane; 1-10% by weight type A fish oil; and the remainder adjuvant. The adjuvant contained in the agent is preferably polysorbate 80.; It is proposed that this agent for the treatment of influenza and viral respiratory infections be used in an amount of from 1 to 10 mg of 3,3-diindolylmethane per kilogram of patient body weight.
Patent EP-3068393-A2 (EP)
Inventor: CAENEPEEL SEAN
IPC: A61P35/00
Filed: 2014-11-11
Abstract: The present invention provides combination therapy that includes an MDM2 inhibitor and one or more additional pharmaceutically active agents, particularly for the treatment of cancers. The invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.
Patent EP-3087227-A2 (EP)
Title: Gebäude, insbesondere krankenhaus
Inventor: GEIGER GUNTER
IPC: A61G10/00
Filed: 2014-12-23
Abstract: Die Erfindung betrifft ein modular aufgebautes Krankenhaus, welches aus stapelbaren Patientenmodulen besteht und welches von außen über einen Versorgungsturm versorgt wird, ohne dass sich die Versorgungswege mit Patientenwegen überschneiden.
Patent EP-2995038-A2 (EP)
Inventor: TUMULAK DEREK
IPC: H04L9/32
Filed: 2014-05-05
Abstract: A method of managing keys and policies is provided. The method includes communicating policies from a key and policy manager in an enterprise environment to an agent in a cloud environment. The method includes generating keys at the key and policy manager and distributing one or more of the keys to computing or communication devices in the enterprise environment, in accordance with the policies. The method includes enforcing the policies in the cloud environment via an application of the policies by the agent, wherein at least one method operation is executed through a processor.
Patent EP-2930499-A2 (EP)
Inventor: MOSS ROBERT AUSTIN
IPC: G01N27/04
Filed: 2015-03-18
Abstract: A humidity sensor arrangement for providing temperature compensated measurements. A first sensor is configured internal to a housing for the sensor arrangement, and a second sensor is configured external to the housing. The first sensor measures a first relative humidity at a first temperature, and the second sensor measures second temperature external. A processor determines saturation pressures for the first and second sensors and compensates the first sensor by adjusting the relative humidity for the first sensor to be a product of the relative humidity for the first sensor and a ratio of the saturation pressure of the first and second sensors. Further compensation may be produced by applying a time-based filter algorithm to the outputs of the first and second sensors. Temperature sensors can be compensated to determine room temperature and compensated temp can be used for precise humidity compensation.
Patent EP-2937593-A2 (EP)
Title: Gasdruckfeder
Inventor: ELFERS HEINZ
IPC: F16F9/32
Filed: 2015-03-31
Abstract: Die Erfindung betrifft eine Gasdruckfeder (10, 10', 10", 10"', 10"") mit einem zylindrischen Gehäuse (20), welches eine Wandung (22), ein Bodenteil (24) und ein eine Öffnung (28) aufweisendes Deckelteil (26) sowie eine Längsachse (1) aufweist, und mit einem in dem Gehäuse (20) entlang der Längsachse (1) verschiebbaren Kolben (30) mit einer Außenfläche (32) und einer Stirnseite (34), wobei zwischen dem Kolben (30) und dem Gehäuse (20) eine Gaskompressionskammer (40) gebildet ist und wobei die Gasdruckfeder (10, 10', 10", 10"' , 10"") wenigstens einen Sensor (50) zur Detektion wenigstens einer physikalischen Größe aufweist, wobei der wenigstens eine Sensor (50) und eine Elektronik (52) zur Verarbeitung der mit dem wenigstens einen Sensor detektierten Werte innerhalb der Außenmaße des zylindrischen Gehäuses (20) angeordnet ist.
Patent EP-2942014-A2 (EP)
Inventor: MANUZZATO GIANLUCA
IPC: F16B2/18
Filed: 2015-04-16
Abstract: Craniostat (20) for an extraoral dental radiographic apparatus (1), comprising a chin rest (52), a bite (54), both of which optionally removable, said bite (54) has centring surfaces having a predefined orientation with respect to a centring position of the bite itself, the bite being blocked in the blocking position through the tightening of said surfaces against tightening surfaces also having a predefined orientation with respect to a bite centring position, so that in tightened condition the bite (54) is also automatically brought in the correct centring position on the sagittal plane. 
     Moreover, a method of use of the craniostat is described.
Patent EP-2995751-A2 (EP)
Inventor: LEMOINE GEORGE
IPC: E04H15/48
Filed: 2015-09-09
Abstract: Erectable shelter frame structures comprising a plurality of rib assemblies (10). Preferably, each rib assembly (10) has a receptacle (26) for receiving a respective end of a purlin arrangement (28), the other end of which is attached to a receptacle of a subsequent rib assembly (10). The joints (12, 14, 16) are comprised of toggle clamps (100) that assist in facilitating the ease by which the shelter structure can be assembled or disassembled. Methods of construction and disassembly of the shelter frame structure are also disclosed.
Patent EP-3102197-A2 (EP)
Inventor: DE SAUVAGE FREDERIC J
IPC: C07D293/00
Filed: 2015-02-04
Abstract: The emergence of mutations in tyrosine kinases following treatment of cancer patients with molecular-targeted therapy represents a major mechanism of acquired drug resistance. Here, mutations in the serpentine receptor, Smoothened (SMO) are described, which result in resistance to a Hedgehog (Hh) pathway inhibitor, such as in medulloblastoma. Amino acid substitutions in conserved residues of SMO maintain Hh signaling, but result in the inability of the Hh pathway inhibitor, GDC-0449, to bind SMO and suppress the pathway. In some embodiments, the disclosure provides for novel mutant SMO proteins and nucleic acids and for screening methods to detect SMO mutations and methods to screen for drugs that specifically modulate mutant SMO exhibiting drug resistance.
Patent EP-3116665-A2 (EP)
Inventor: KRAUSE WILLIAM R
IPC: A61B34/00
Filed: 2015-03-11
Abstract: An apparatus for cleaning cannulated surgical tools comprises a hollow body with lavage fluid holes at a first end along with a brush adaptor affixed to the hollow body. An inlet adaptor is affixed, having to a second end of the hollow body. A body hub, consisting of inlet channel and drain channel is in liquid communication with an inner lavage fluid tube. A lavage connection tube is in liquid communication with the hollow body at the brush adaptor and through the upper connecting lavage fluid orifice. An inner lavage fluid tube, having an inner channel, extends within the hollow body with a distal end in liquid communication at a proximal end of the inner channel within the inlet adaptor. There are multiple spray openings proximate the distal end of the inner lavage fluid connection tube and a tube brush is dimensioned to fit within the inner channel. The apparatus can be provided with attachment members and combined with a reservoir to make the unit self-contained.
Patent EP-3215528-A2 (EP)
Inventor: MOESSNER EKKEHARD
IPC: C07K16/22
Filed: 2015-11-04
Abstract: L'invention concerne un fragment Fc d'IgG comprenant un premier polypeptide variant du fragment Fc et un second polypeptide variant du fragment Fc. a) Le premier polypeptide variant du fragment Fc est issu d'un premier polypeptide parent du fragment Fc d'IgG et le second polypeptide variant du fragment Fc est issu d'un second polypeptide parent du fragment Fc d'IgG, le premier polypeptide parent du fragment Fc d'IgG étant identique au second polypeptide parent du fragment Fc d'IgG ou différent de celui-ci, b) le premier polypeptide variant du fragment Fc diffère du second polypeptide variant du fragment Fc en ce qui concerne un ou plusieurs résidus d'acides aminés autres que ceux au niveau desquels le premier polypeptide parent du fragment Fc d'IgG diffère du second polypeptide parent du fragment Fc d'IgG, et c) le fragment Fc d'IgG comprenant le premier polypeptide variant du fragment Fc et le second polypeptide variant du fragment Fc présente une affinité pour un récepteur Fc humain qui est différent de celui d'un fragment Fc d'IgG comprenant le premier polypeptide parent du fragment Fc d'IgG selon a) et le second polypeptide parent du fragment Fc d'IgG selon a), le premier polypeptide du fragment Fc et/ou le second polypeptide du fragment Fc présentant, indépendamment l'un de l'autre, l'une des mutations ou combinaisons de mutations suivantes : T307H, ou Q311H, ou E430 H, ou N434H, ou T307H et Q311H, ou T307H et E430H, ou T307H et N434A, ou T307H et N434H, ou T307Q et Q311H, ou T307Q et E430H, ou T307Q et N434H, ou T307H et Q311H et E430H et N434A, ou T307H et Q311H et E430H et N434H, ou T307H et Q311H et E430H et N434Y, ou T307Q et Q311H et E430H et N434A, ou T307Q et Q311H et E430H et N434H, ou T307Q et Q311H et E430H et N434Y, ou T307Q et V308P et N434Y et Y436H, ou T307H et M252Y et S254T et T256E, ou T307Q et M252Y et S254T et T256E, ou Q311H et M252Y et S254T et T256E, ou E430 H et M252Y et S254T et T256E, ou N434H et M252Y et S254T et T256E, ou T307H et Q311H et M252Y et S254T et T256E, ou T307H et E430H et M252Y et S254T et T256E, ou T307H et N434A et M252Y et S254T et T256E, ou T307H et N434H et M252Y et S254T et T256E, ou T307Q et Q311H et M252Y et S254T et T256E, ou T307Q et E430H et M252Y et S254T et T256E, ou T307Q et N434H et M252Y et S254T et T256E, ou T307H et Q311H et E430H et N434A et M252Y et S254T et T256E, ou T307H et Q311H et E430H et N434H et M252Y et S254T et T256E, ou T307H et Q311H et E430H et N434Y et M252Y et S254T et T256E, ou T307Q et Q311H et E430H et N434A et M252Y et S254T et T256E, ou T307Q et Q311H et E430H et N434H et M252Y et S254T et T256E, ou T307Q et Q311H et E430H et N434Y et M252Y et S254T et T256E, ou T307Q et V308P et N434Y et Y436H et M252Y et S254T et T256E.
Patent EP-3180807-A2 (EP)
Inventor: TIMM EDWARD J
IPC: H01L35/32
Filed: 2015-08-12
Abstract: L'invention concerne un dispositif thermoélectrique (20) et un procédé de fabrication et d'utilisation de celui-ci. Le dispositif thermoélectrique (20) comprend un sabot chaud (24) et un sabot froid (28) disposé autour du sabot chaud. Un élément conducteur de chaleur (32) formé à partir d'un matériau thermoélectrique s'étend entre le sabot chaud (24) et le sabot froid (28) et génère de l'électricité en réponse à une différence de température entre ceux-ci. Le sabot chaud (24) est chauffé et se dilate à une vitesse supérieure par rapport au sabot froid (28) en cours de fonctionnement. La relation en termes de structure et d'espace du sabot chaud (24) et du sabot froid (28) maintient le matériau thermoélectrique de l'élément conducteur de chaleur (32) en compression pendant le fonctionnement du dispositif thermoélectrique (20).
Patent EP-3116267-A2 (EP)
Title: Apparatuses and methods for cell selection or reselection with application-specific congestion control for data communication (acdc), and storage medium thereof
Inventor: TSAI WEI-CHIEH
IPC: H04W48/20
Filed: 2016-02-01
Abstract: A mobile communication device including a wireless transceiver and a controller is provided. The wireless transceiver performs wireless transmission and reception to and from a service network comprising a plurality of cells. The controller determines whether an Application-specific Congestion control for Data Communication (ACDC) has not been enabled in one of the cells according to system information broadcasted by the cells, and in response to the ACDC not having been enabled in one of the cells, select or reselect to the cell via the wireless transceiver even when the cell has a lower priority level than another cell in which the ACDC has been enabled.
Patent EP-3058945-A2 (EP)
Title: Pharmaceutical compositions and formulations for topical application with astringent and antimicrobial effect
Inventor: ROMANO PAOLO
IPC: A61K31/185
Filed: 2016-02-15
Abstract: A powder composition comprising calcium acetate monohydrate, aluminum sulfate tetradecahydrate and a third component selected from potassium permanganate (KMnO 4 ) and chloramine-T (sodium N-chloro-4-toluenesulfonamidate), and a pharmaceutical formulation for topical application comprising the aforementioned components and a pharmaceutically acceptable carrier are described; a pharmaceutical formulation comprising basic aluminum acetate and a component selected from potassium permanganate and chloramine-T is also described; such pharmaceutical formulations are intended for use in the topical treatment of skin conditions such as swelling, hives, eczemas, erythemas, insect bites, bruises, itching, vesicular or bullous exudation, crusted lesions, skin ulcers, atopic dermatitis, herpes zoster, herpes simplex, intertrigo and sunburn.
Patent EP-3222245-A2 (EP)
IPC: A61C17/02
Filed: 2016-08-19
Abstract: The invention relates to an arrangement for the cleaning of a circumferentially closed canal by means of a light guide conducting a laser beam. The entry of the laser beam into the light guide is interrupted when the free end of the light guide is outside of the canal and/or the movement of the light guide within the canal is monitored and that if there is no movement or the movement is below a threshold value then a signal is triggered and/or the laser radiation is turned off or its output is reduced.
Patent EP-3344133-A2 (EP)
Inventor: WARD JAY M
IPC: G01R1/073
Filed: 2016-09-02
Abstract: L'invention concerne un appareil et un procédé pour un câble d'électrocardiogramme (ECG) appropriés à une utilisation à l'intérieur d'un scanner à résonance magnétique (RM) au cours d'une imagerie par résonance magnétique (IRM). En particulier, la présente invention concerne un câble d'ECG sans danger pour les patients (IRM conditionnel) à 12 dérivations pouvant être utilisé à l'intérieur d'un scanner de RM pendant une IRM. Le câble d'ECG ne chauffe pas jusqu'à un degré qui pourraient brûler un patient soumis à un analyse IRM, mais permet aussi le placement d'une électrode d'ECG à 12 dérivations classique nécessaire pour le suivi du diagnostic du patient. Spécifiquement, les électrodes à câble d'ECG peuvent être placées sur un patient dans la configuration classique en tant que câble d'ECG à 12 dérivations conçu pour être utilisé à l'extérieur d'un scanner à RM de diagnostic, et faire des lectures de niveau de diagnostic pendant le fonctionnement d'un dispositif ou d'un système à RM. De plus, le câble offre une protection continue qui maintient des émissions zéro, tout en satisfaisant des exigences de défibrillation.
Patent EP-3255354-A2 (EP)
Inventor: PINKALLA CARY
IPC: F24F13/02
Filed: 2015-05-18
Abstract: The invention provides an air duct assembly comprising: 
an air duct (16) elongate in a longitudinal direction (24), the air duct (16) comprising a sidewall (18) that is pliable, the sidewall (18) being tubular and defining an interior (26) of the air duct (16) and an external area (28) outside the air duct (16); 
an overhead support member (36, 36a, 36b, 36c) in the external area (28) outside the air duct (16); 
a hoop (34) disposed within the interior (26) of the air duct (16), the hoop (34) providing the sidewall (18) with support in a radial direction (64) that is substantially perpendicular to the longitudinal direction (24); and 
a bracket (78) passing through an opening (80) in the sidewall (18) and extending from the hoop (34) to the overhead support member (36), the bracket (78) being more rigid than the sidewall (18), and the bracket (78) cooperating with the hoop (34) to subject the air duct (16) to tension in the longitudinal direction (24), the bracket (78) and the hoop (34) being non-adjustably coupled.